Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dr. Reddy's
Biotech
Coya taps familiar friend Dr. Reddy's to commercialize ALS med
Coya is receiving more than $7 million in upfront cash from Dr. Reddy's for crucial commercialization rights to ALS treatment COYA-302.
Max Bayer
Dec 6, 2023 11:20am
Chutes & Ladders—Gilead cancer clinical chief jumps to Compugen
Mar 30, 2018 8:15am
Encore's first pipeline play is psoriasis drug from Dr. Reddy's
Aug 22, 2017 10:32am
